HEPATITIS; CRISIS OF PEOPLE

 

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT editor-in-chief@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE

VACCINATION
Vaccination consists of two doses of vaccines in a period of 6-12months, within the first dose administration only 100% the people developed antibodies against the viruses and second dose acts as a booster dose. In HEV-3 infection was treated with

PREVENTION
The preventing measures includes
* Proper diet, hygienic condition,
* To maintain the areas are aseptic
* To avoid the close physical contact by the infected person
* Proper vaccination (seyed Mohammad,2008).
* Ribavirin(Charlotte,2015).
* To improve the individual education, it can reduce the infection rate
* To test the blood samples during blood transfusions
* During pregnancy condition the mother is effecting the infection to control the infection mother itself only then there is no chance to get the child, to prevent the neonatal infection by the administration of HBV immunoglobins, In between the period of 1981-1982 HBV vaccinations are available, the vaccinations should be given in the period of 0,1,2&6months in the form of 3 doses to achieve adequate immune response(Elisabetta Franco,2012).

Currently there is no vaccination on HCV so we have to avoid spread and transfer of infection/diseases, to cover the cuts and scratches with an appropriate dressing (https://www.hepatitisfoundation.org.nz/). To practise safe sex, Avoiding drug sharing equipment’s (https://emedicine.medscape.com/article/177792-overview).
* To sterilize the blood tools and needles
* To take safety measure in blood transfusion
* To prevent the HBV transmission
* To cook meat and meat products properly and thoroughly
* Avoid raw meat and uncooked food
* Proper hand wash should be needed for preparing, serving, and eating food
* Drink boiled water(www.who.int).

CONCLUSION
The viral hepatitis one of most complicated disease. The risk ratio is more in underdeveloped   and developing countries because of poverty it leads to unhygienic conditions it is one of the drawback. By educating the common and effected people we can reduce the affected ratio and improve the public health. The suitable word in these disease “prevention is better than cure” because the affected persons are recovered by longer periods  by taking prolonged treatment. Advanced treatment are under clinical trials it takes much time to reach the patient. The common and affected people are suffered a lot with these disease, preventing measure are best of eradication of hepatitis.

REFERENCES
1. Abbas Z, Afzal R. Life cycle and pathogenesis of hepatitis D virus (2013) ; A review. World J Hepatol ; 5(12): 666-675 .
2. Arvind R Murali, Vikram kowal, and saurabhChawla. Chronic hepatitis E (2015) ; A brief review, World J Hepatol.  ; 7(19): 2194–2201.
3. Ahmed A, Ali IA, Ghazal H, Fazili J, Nusrat S. (2015) ; Mystery of hepatitis e virus: recent advances in its diagnosis and management., Int J Hepatol. ;2015:872431. doi: 10.1155/2015/872431.
4. Blanca san ,using the journal bmj case reports to promote the publication of clinical case reports,J Med libr Assc 104(4) oct 2016.
5. Chan Ran You, Sung Won Lee, Jeong Won Jang, and Seung Kew Yoon ,(2014) ; Update on hepatitis B virus infection, World J Gastroenterol. ; 20(37): 13293–13305.
6. corolinaalves, eritima Branco. advances in virology, volume 201392013), article 1d560105.11pages accessed from  http;//dx.doi.org.115/2013/560105.
7. Chou R, Hartung D, Rahman B, et al.Treatment for Hepatitis C Virus Infection in Adults [Internet], Comparative Effectiveness Reviews, No. 76: Agency for Healthcare Research and Quality (US); 2012 Nov www.ahq.gov .Charlotte M. Nijskens, Suzan D. Pas,(2015) ; Annemiek A. van der Eijk,Robert A. de Man. Hepatitis e in europe: diagnosis and treatment, EMJ Gastroenterol  ;4[1] :121-127.
8. Dastgerdi ES1, Herbers U, Tacke F.(2012) ; Molecular and clinical aspects of hepatitis D virus infections. World J Virol. ;1(3):71-78
9. Elgouhari HM , Abu-Rajab Tamimi TI , Carey WD .(2008) ; Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis., Cleveland clinic journal of medicine ; 75(12)881-889.
10. Elisabetta Franco, Cristina Meleleo, Laura Serino, Debora Sorbara, Laura Zaratti. (2012) ; Hepatitis A: Epidemiology and prevention in developing countries,World J Hepatol ; 4(3): 68–73.
11. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. (2012) ; Hepatitis A: Epidemiology and prevention in developing countries, World J Hepatol. ;4(3):68-73.
12. Goldberg DS, FrenchB et al, (2016);  liver transplant center variability in accepting organ offers and its impact on patient survival.  J Hepatol. apr,64(4):843-51.
13. 1https://www.cdc.gov/hepatitis/index.html
14. https://emedicine.medscape.com/article
15. Hoofnagle JH1, Nelson KE, Purcell RH.,  (2012) ; Hepatitis E.N Engl J Med. ;367(13):1237-44.
16. https://www.hepatitisfoundation.org.nz/
17. https://www.doh.wa.gov/Portals/1/Documents/.../420-042-Guideline-Hepatit....
18. Jake Liang .Hepatitis B :The virus and disease ,hepatology, 2009 may; 49(5suppl s13-s21). accesed from  http://aasldpubs.onlinelibrary.wiley.com
19. James , smith, (2001) ; A Review of Hepatitis E Virus, , Journal of Food Protection, 64(4) : 572–586 .
20. James M. Hughes Mary E. Wilson Eyasu H. Teshale Dale J. Hu Scott D. Holmberg, (2010) ; The Two Faces of Hepatitis E Virus ,Clinical Infectious Diseases, Volume 51(3) : 328–334
21. Jennifer A. Cuthbert. (2001) ; Hepatitis A: Old and New, , clin.microbial.Rev. Jan  14 : 38-58.
22. jules L Dienslag ,acute viral hepatitis ,pg no 2004, Harrisons  principles of internal medicine
23. Kamar, Lhomme, S.; Abravanel, F.; Marion, O.; Peron, J.-M.; Alric, L.; Izopet, J. Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses 2016, 8, 222
24. Kumar S, Subhadra S, Singh B, Panda BK. (2013) ; Hepatitis E virus: the current scenario.Int J Infect Dis. ;17(4):e228-33.
25. Kathleen davisFNP published Thu 31 march 2006.
26. Nassim Kamar, Harry R. Dalton, (2014) ; Florence Abravanel, Jacques Izopet,Hepatitis E Virus Infection.Clin Microbiol Rev. ; 27(1): 116–138.
27. Noureddin M, Gish R. (2014) ; Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery, Curr Gastroenterol Rep. ;16(1):365
28. Nikolas. Tpysorpolous article/177632 overview. accessed from www.medscape.com. 20- 54-30
29. Rakesh Aggarwal ,Shahid Jameel (2011) ; Hepatitis E, , hepatology, Vol. 54(6) : 2218-2226
30. Richard k, Gilroy. (2008) ; Cleveland clinic journal of medicine ; 75(12) : 881-889.
31. Sandra Rodriguez, Hepatitis E –An Evoving disease,Cleveland clinic accessed from http://www.clevelandclinicmeded.com/medicalpubs/disesemangement/hepatolo...
32. S Mohmammad, E Tahaei, atl (2014); Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran ; 7(3) : 144-150
33. Shaina M. Lynch, George Y. Wu.Hepatitis C Virus ; (2016) ;  A Review of Treatment Guidelines, Cost-effectiveness, and Access to Therapy.J Clin Transl Hepatol. 4(4): 310–319.
34. Severin Gudima, Jinhong Chang, Gloria Moraleda, Anna Azvolinsky, John Taylor. (2002) ; Parameters of Human Hepatitis Delta Virus Genome Replication: the Quantity, Quality, and Intracellular Distribution of Viral Proteins and RNA, J. Virol. 76(8): 3709-3719.
35. Sultanik and Pol .Hepatitis Delta Virus: Epidemiology, Natural Course and Treatment, , J Infect Dis Ther 2016, 4:2
36. Sultanik P, Pol S (2016) Hepatitis Delta Virus: Epidemiology, Natural Course and Treatment. J Infect Dis Ther 4(2) : 271
37. Shobha N. Joshi (2014) ; Hepatitis C Screening, Ochsner J.  Winter; 14(4): 664–668.
38. Praveen k Roy ,Hepatitis D: Background, Etiology, Epidemiology, same  https://emedicine.medscape.com/article/178038-overview.
39. Phusa et al. Health line medically reviewed hepatitis D.acta.virol 49(4) 219225.2005.
40. Pallavi K, Sravani D, Durga S, et al. , Hepatitis Review on Current and Future Scenario. J In Silico In Vitro Pharmacol. 2017, 3(1) : 1-5
41. Tang CM et al. (2014) ; management of chronic hepatitis B infection. world J Gastroenterol  ;20(20):6262-6278.
42. T. Jake Liang ,(2009); Hepatitis B: The Virus and Disease, Hepatology.  49(5): S13–S21.
43. Thad wilkins, md; jennifer k. malcolm, do; dimple raina, md; and robert r. schade .Hepatitis C: Diagnosis and Treatment,Am Fam Physician. 2010 Jun 1;81(11):1351-1357.
44. Trépo C1, Chan HL2, Lok A3.(2014) ; Hepatitis B virus infection., Lancet.  384(9959):2053-63
45. Vinay sundaram, (2015) ; Mangement of chronic hepatitis B infection ,BMJ ;351:h4263.
46. Vasickova, Psikal , Kralik ,(2007) ; Hepatitis E virus: a review, Veterinarni Medicina, 52(9): 365–384 .
47. Vinod k Dhawan, MD e  medicine ; www.medscape.com/article 177792clinov
48. www.gideononline.com
49. www.whoint.  ; epidemiology and statics of hepatitis D virus
50. www.altiusdirectory.com/Health/hepatitis-d.html
51. www.who.int/hiv/pub/hepatitis/framework/en/
52. www.whoint. WHO safety measure and guidelines of prevention of hepatitis.
53. Zhang J1, Nguyen D2, Hu KQ1. (2016) ; Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies, N Am J Med Sci (Boston). ;9(2):47-54

NOW YOU CAN ALSO PUBLISH YOUR ARTICLE ONLINE.

SUBMIT YOUR ARTICLE/PROJECT AT editor-in-chief@pharmatutor.org

Subscribe to Pharmatutor Alerts by Email

FIND OUT MORE ARTICLES AT OUR DATABASE


Pages

FIND MORE ARTICLES